Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes

Author:

Shah Nikhil1,Karguppikar Madhura1,Bhor Shital1,Ladkat Dipali1,Khadilkar Vaman12,Khadilkar Anuradha12ORCID

Affiliation:

1. Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital , Pune , Maharashtra , India

2. Interdiscplinary School of Health Sciences , Savitribai Phule University , Pune , India

Abstract

Abstract Objectives In March 2020, lockdown was imposed in India to combat spread of Coronavirus, which was extended till 31st May. Implementation of lockdown and limited outdoor activities resulted in changes in routines of children with diabetes. The aim of this study was to assess the impact of lockdown on glycemic control, weight and body mass index (BMI) patterns of children with type 1 diabetes (T1DM) from different socio-economic (SE) classes. Methods This observational study included 77 children and youth (5–20 years) with T1DM having disease duration of ≥6 months. Demographic data and investigations were recorded at two time points (post lockdown when the children came for follow up, pre lockdown data from medical records). Results Glycemic control improved (pre lockdown HbA1C 79.4±19.2 vs. post lockdown Hba1C 74.5±16.9 mmol/mol, p<0.05) and there was weight gain post lockdown (pre lockdown weight z-score −0.4±0.8 vs. post lockdown weight z-score −0.2±0.8, p<0.05) without any significant change in BMI and insulin requirements. Improved glycemic was seen in the lower SE group control post lockdown (p<0.05), whereas in higher SE group, it remained unchanged. Children whose parents were at home during lockdown showed an improved glycemic control (p<0.05) as compared to children whose parents continued to work during lockdown (p>0.01) Conclusions During coronavirus lockdown, glycemic control was adequately maintained in children with T1DM, highlighting importance of stronger family support system leading to more steady daily routine.

Publisher

Walter de Gruyter GmbH

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Reference23 articles.

1. Cascella, M, Rajnik, M, Cuomo, A, Dulebohn, SC, Napoli, RD. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls, [Updated 2020 Jul 4]. Treasure Island (FL): StatPearls Publishing; 2020. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/.

2. Arunachalam, MA, Halwai, A. An analysis of the ethics of lockdown in India. [published online ahead of print, 2020 Jul 9]. Asian Bioeth Rev 2020:1–9. https://doi.org/10.1007/s41649-020-00133-3.

3. Saha, J, Barman, B, Chouhan, P. Lockdown for COVID-19 and its impact on community mobility in India: an analysis of the COVID-19 Community Mobility Reports, 2020. Child Youth Serv Rev 2020;116:105160. https://doi.org/10.1016/j.childyouth.2020.105160.

4. Rajgopal, T. COVID-19: epidemiology and public Health aspects. Indian J Community Med 2020;45:111–16. https://doi.org/10.4103/ijcm.IJCM_167_20.

5. International Diabetes Federation. IDF Diabetes Atlas., 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3